CRA was retained by respondent to provide expert reports and testimony in an ICC arbitration regarding the use of commercially reasonable efforts following the purchase of a medical device technology. CRA analyzed the development and commercialization decisions made by the respondent in the context of an evolving market for the device at issue. CRA also analyzed the damages claim put forth by claimant, showing that the damages claim was not related to asserted failures in respondent’s conduct of commercially reasonable efforts.
2024 International Arbitration review: Updates and trends
Dear Clients and Friends, Our activities in 2024 reflected ongoing trends from 2023 and emerging forces affecting the landscape for investors and companies...